{
    "title": "Japan approves Alzheimer's treatment Leqembi by Eisai and Biogen",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12558265/Japan-approves-Alzheimers-treatment-Leqembi-Eisai-Biogen.html",
    "date": "2023-09-25",
    "keywords": [
        "health",
        "japan",
        "drug",
        "leqembi",
        "treatment",
        "biogen",
        "ministry",
        "use",
        "approval",
        "eisai",
        "progression",
        "move",
        "tokyo",
        "monday",
        "countrys",
        "nation",
        "impairment",
        "dementia",
        "antibody",
        "protein",
        "beta",
        "disease",
        "panel",
        "nod",
        "food",
        "administration",
        "fda",
        "july",
        "aduhelm",
        "coverage",
        "postmarketing",
        "survey",
        "number",
        "accordance",
        "condition",
        "risk",
        "brain",
        "class",
        "executive",
        "august",
        "company",
        "insurance",
        "reimbursement",
        "system",
        "product",
        "marketing",
        "authorization",
        "holder",
        "reporting",
        "sugiyama",
        "pratik",
        "jain",
        "bengaluru",
        "editing",
        "rashmi",
        "aich",
        "arun",
        "koyyur"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}